AstraZeneca
AZN
AZN
1,265 hedge funds and large institutions have $37.8B invested in AstraZeneca in 2025 Q3 according to their latest regulatory filings, with 159 funds opening new positions, 538 increasing their positions, 356 reducing their positions, and 74 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
9% more capital invested
Capital invested by funds: $34.7B → $37.8B (+$3.19B)
4% more funds holding
Funds holding: 1,212 → 1,265 (+53)
0.08% less ownership
Funds ownership: 15.99% → 15.91% (-0.08%)
Holders
1,265
Holding in Top 10
21
Calls
$559M
Puts
$303M
Top Buyers
| 1 | +$222M | |
| 2 | +$207M | |
| 3 | +$139M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$135M |
| 5 |
Goldman Sachs
New York
|
+$127M |
Top Sellers
| 1 | -$651M | |
| 2 | -$484M | |
| 3 | -$216M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$156M |
| 5 |
D.E. Shaw & Co
New York
|
-$128M |
